Eli Lilly outlays $3.35bn for secretive drug discovery pact with China’s InnoCare
Eli Lilly has partnered with China-based InnoCare Pharma in a five-drug strong research and license pact. As per the deal, Lilly …
Post
-
-
Australia starts investigation into OpenAI Medicare breach
The Australian government has initiated a review into a hacking incident in which tech giant OpenAI’s artificial intelligence (AI) model …
-
Podcast: How Sandoz plans to harness its “golden decade”
At its Capital Markets Day on 8 September, Sandoz revealed a new set of targets – part of a roadmap …
-
Enveda nabs $311m to progress nature-derived drug pipeline
Colorado-based biotech Enveda has closed a $311m Series E funding round to advance its pipeline of artificial intelligence (AI)-discovered therapies …
-
Genialis and Inventia to enhance pancreatic cancer treatment testing
Genialis has teamed up with Inventia Life Science to enhance the testing of pancreatic cancer treatments and match them to …
-
FDA approves Lilly’s Onswik for type 2 diabetes in adults
The US Food and Drug Administration (FDA) has approved Eli Lilly and Company’s Onswik (insulin efsitora alfa-gobe), a once-weekly basal …
-
Eli Lilly outlays $3.35bn for secretive drug discovery pact with China’s InnoCare
Eli Lilly has partnered with China-based InnoCare Pharma in a five-drug strong research and license pact. As per the deal, Lilly …
-
Australia starts investigation into OpenAI Medicare breach
The Australian government has initiated a review into a hacking incident in which tech giant OpenAI’s artificial intelligence (AI) model …
-
Podcast: How Sandoz plans to harness its “golden decade”
At its Capital Markets Day on 8 September, Sandoz revealed a new set of targets – part of a roadmap …
-
Enveda nabs $311m to progress nature-derived drug pipeline
Colorado-based biotech Enveda has closed a $311m Series E funding round to advance its pipeline of artificial intelligence (AI)-discovered therapies …
-
Genialis and Inventia to enhance pancreatic cancer treatment testing
Genialis has teamed up with Inventia Life Science to enhance the testing of pancreatic cancer treatments and match them to …
-
Basecamp Research secures $140m for AI-driven therapies
UK-based Basecamp Research has secured $140m in a Series C funding round to train a new generation of its EDEN …
-
European big pharma unites amid ‘ringing alarm bells’ of continent’s dominance
The boardrooms of all European big pharma companies have issued a stark warning regarding the current competitiveness of the continent’s …
-
How China’s rise as a biopharma innovation hub is reshaping global dealmaking strategies
A new Intelligence Briefing from GlobalData Healthcare suggests that China is becoming an increasingly strategic component of international growth strategies …
-
BoomRay and Novartis sign $900m deal for radioligand therapy
China-based clinical-stage biotechnology company BoomRay Pharmaceuticals and Novartis have signed an exclusive worldwide licence deal for an undisclosed preclinical radioligand …
